Articles tagged with "apremilast"

Apremilast Most Helpful for Mild to Moderate Psoriatic Arthritis

May 18, 2020 • By Lara C. Pullen, PhD

FDA Update: New Drug Approvals, New & Expanded Indications, & More

March 12, 2020 • By Susan Bernstein

Risankizumab & Apremilast Come to Market in Canada

March 9, 2020 • By Michele B. Kaufman, PharmD, BCGP

Case Report: A Patient on Apremilast Develops Streptococcus Salivarius

October 18, 2019 • By Stephanie Kydd Dondero, DO, & Barry Waters, MD

MicroOne / shutterstock.com

Rheumatology Drugs at a Glance, Part 2: Psoriasis

May 17, 2019 • By Mary Choy, PharmD, BCGP, FASHP

kenary820 / shutterstock.com

Rheumatology Drugs at a Glance, Part 1: Psoriatic Arthritis

April 15, 2019 • By Mary Choy, PharmD, BCGP, FASHP

Long-Term Apremilast Promising for Psoriatic Arthritis

July 27, 2018 • By Michele B. Kaufman, PharmD, BCGP

Study Results for 9 New Psoriatic Arthritis Drugs

June 21, 2018 • By Thomas R. Collins

Sarilumab Approval Stalled; Piclidenoson Promising for Psoriasis

November 16, 2016 • By Michele B. Kaufman, PharmD, BCGP

Rheumatology Drug Updates: Biosimilars Receive Positive News & More

April 13, 2016 • By Michele B. Kaufman, PharmD, BCGP